Here, we explored the prognostic role of the KLF11 by performing immunohistochemistry (IHC) staining of KLF11 in 298 samples of BC patients, followed by clinicopathological correlation and survival analysis to assess the clinical significance of KLF11. Here, KLF11 is linked to breast cancer.